Abiopharma

Ensign Group - The Ensign Group Purchases Skilled Nursing Facility in Texas

Ensign Group - The Ensign Group Continues Growth in Idaho

Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors

The Ensign Group Purchases Skilled Nursing Facility in Texas

The Ensign Group Continues Growth in Idaho

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

FDA approve CALCIUM CHLORIDE

FDA approve EXEMESTANE

Inozyme Pharma Inc. (INZY) was removed from the list of traded instruments on NASDAQ exchange

SpringWorks Therapeutics (SWTX) was removed from the list of traded instruments on NASDAQ exchange

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: SpringWorks Therapeutics, Inc. - common stock.

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Inozyme Pharma, Inc. - Common Stock.

NASDAQ symbol attribute type Security_Name was changed. Previous value: SpringWorks Therapeutics, Inc. - common stock. New value: SpringWorks Therapeutics, Inc. - common stock.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Inozyme Pharma, Inc. - Common Stock.

NASDAQ symbol attribute type Security_Name was changed. Previous value: Inozyme Pharma, Inc. - Common Stock. New value: Inozyme Pharma, Inc. - Common Stock.